Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended June 30, 2025
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has filed a routine compliance certificate with the stock exchanges for the quarter ended June 30, 2025. The certificate was issued by Cameo Corporate Services Limited, the company's Registrar and Share Transfer Agent (RTA), as required under SEBI's Depositories Regulations. It confirms that share certificates received from shareholders for conversion into electronic (demat) form during the quarter were processed within the stipulated time. It also confirms that the physical certificates were cancelled and the depository's name was entered in the company's register of members as the new registered owner. No new shares were issued or transferred — this is purely a procedural confirmation of existing dematerialisation activity.
This is a standard quarterly compliance filing with no impact on business operations, financials, or share price. Investors can ignore it as routine regulatory housekeeping.